logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
W

Wei-Yu Liao

national taiwan university
H指数:35
被引数:3,426

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical utility of pleural effusion supernatant cell-free DNA genotyping in previously treated patients with advanced non-small-cell lung cancer and disease progression: a multicenter retrospective study

胸水上清液游离DNA基因分型在既往接受治疗且疾病进展的晚期非小细胞肺癌患者中的临床应用价值：一项多中心回顾性研究

ESMO Open
IF8.3
2025-12-290
OAAI
S.-C. Chang; C.-Y. Huang; Y.-C. Lai; M.-S. Hsieh; C.-C. Ho; C.-Y. Yang; J.-Y. Shih; S.-G. Wu; P.-W. Hu; C.-L. Hsu; C.-Y. Chen; W.-Y. Liao
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis

Atezolizumab，bevacizumab，培美曲塞和铂类用于EGFR TKI失败后的EGFR突变NSCLC患者: 免疫细胞谱分析的II期研究

CLINICAL AND TRANSLATIONAL MEDICINE
IF6.8
2024-12-230
OA
Wu, Shang-Gin; Ho, Chao-Chi; Yang, James Chih-Hsin; Yu, Shu-Han; Lin, Yen-Feng; Lin, Shu-Chin; Liao, Bin-Chi; Yang, Ching-Yao; Lin, Yen-Ting; Yu, Chong-Jen; Chuang, Ya-Ting; Liao, Wei-Yu; Yap, Kah Yi; Kou, Weng Si; Shih, Jin-Yuan
PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational study

PD-L1表达和免疫谱分析无法预测携带EGFR T790 M突变的肺癌中osimertinib的疗效：一项转化研究

Journal of the Formosan Medical Association
IF2.5
2024-12-170
OAAI
Ching-Yao Yang; Wei-Yu Liao; Chao-Chi Ho; Kuan-Yu Chen; Tzu-Hsiu Tsai; Chia-Lin Hsu; Kang-Yi Su; Yih-Leong Chang; Chen-Tu Wu; Chia-Chi Hsu; Yi-Nan Liu; Guan-Ru Peng; Almanzo Aeterna Kangartaputra; Shu-Han Yu; Bin-Chi Liao; Wei-Hsun Hsu; Jih-Hsiang Lee; Chia-Chi Lin; Jin-Yuan Shih; James Chih-Hsin Yang
Upfront liquid next-generation sequencing in treatment- naive advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system

未接受过治疗的晚期非小细胞肺癌患者的前期液体下一代测序: 台湾卫生系统的一项前瞻性随机研究

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-11-011
PRE
Yang, Ching-Yao; Shih, Jin-Yuan; Liao, Wei-Yu; Ho, Chao-Chi; Hsu, Chia-Lin; Tsai, Tzu-Hsiu; Wu, Shang-Gin; Lin, Yen-Ting; Hsu, Wei-Hsun; Jain, Suyog; Olsen, Steve; Yang, James Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr
Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma

患有梭形细胞和/或巨细胞癌的晚期非小细胞肺癌患者的真实世界治疗模式和结果

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2022-10-276
OAAI
Chang, Chia-Ling; Hsieh, Min-Shu; Shih, Jin-Yuan; Lee, Yi-Hsuan; Liao, Wei-Yu; Hsu, Chia-Lin; Yang, Ching-Yao; Chen, Kuan-Yu; Lee, Jih-Hsiang; Ho, Chao-Chi; Tsai, Tzu-Hsiu; Yang, James Chih-Hsin; Yu, Chong-Jen
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study

晚期非小细胞肺癌患者单用第一代egfr-tki超过5年的预测因素的相对重要性: 台湾多中心TIPS-5研究

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2021-05-223
OAAI
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; Ho, Chao-Chi; Chang, Gee-Chen

研究方向

暂未获取到该数据
C
Chong‐Jen Yu
H 指数:89论文数:966被引数:3.7万
J
Jin‐Yuan Shih
H 指数:63论文数:479被引数:1.8万
C
Chao‐Chi Ho
H 指数:37论文数:276被引数:5,695
J
James Chih‐Hsin Yang
H 指数:141论文数:1,223被引数:10.9万
P
Pan‐Chyr Yang
H 指数:121论文数:1,368被引数:6.3万
C
Ching‐Yao Yang
H 指数:18论文数:85被引数:1,712
C
Chia‐Lin Hsu
H 指数:25论文数:94被引数:2,191
J
Jih‐Hsiang Lee
H 指数:22论文数:93被引数:1,488
Y
Yih‐Leong Chang
H 指数:62论文数:494被引数:1.3万
S
Shang‐Gin Wu
H 指数:31论文数:120被引数:3,457